Unknown

Dataset Information

0

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer.


ABSTRACT: KRAS mutant pancreatic ductal adenocarcinoma (PDAC) is characterized by a desmoplastic response that promotes hypovascularity, immunosuppression, and resistance to chemo- and immunotherapies. We show that a combination of MEK and CDK4/6 inhibitors that target KRAS-directed oncogenic signaling can suppress PDAC proliferation through induction of retinoblastoma (RB) protein-mediated senescence. In preclinical mouse models of PDAC, this senescence-inducing therapy produces a senescence-associated secretory phenotype (SASP) that includes pro-angiogenic factors that promote tumor vascularization, which in turn enhances drug delivery and efficacy of cytotoxic gemcitabine chemotherapy. In addition, SASP-mediated endothelial cell activation stimulates the accumulation of CD8+ T cells into otherwise immunologically "cold" tumors, sensitizing tumors to PD-1 checkpoint blockade. Therefore, in PDAC models, therapy-induced senescence can establish emergent susceptibilities to otherwise ineffective chemo- and immunotherapies through SASP-dependent effects on the tumor vasculature and immune system.

SUBMITTER: Ruscetti M 

PROVIDER: S-EPMC7278897 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2020-02-03 | GSE141684 | GEO
| PRJNA594360 | ENA
| S-EPMC7188804 | biostudies-literature
| S-EPMC9530050 | biostudies-literature
| S-EPMC10140597 | biostudies-literature
| S-EPMC3528503 | biostudies-literature
2022-10-15 | PXD033549 | Pride
| S-EPMC3712624 | biostudies-literature
2022-10-12 | GSE193272 | GEO
2021-11-15 | GSE146583 | GEO